Showing 921-930 of 1226 results for "".
- Vance Thompson Vision Announces New Clinic and LASIK and Cataract Center in Omahahttps://modernod.com/news/vance-thompson-vision-announces-new-clinic-and-lasik-and-cataract-center-in-omaha/2480189/Vance Thompson Vision is scheduled to open a new clinic in Omeha, Nebraska, in August and will include a focus on cataract surgery, minimally invasive glaucoma surgery, LASIK, and corneal surgery. Brandon Baartman, MD, is an accomplished refractive, cataract,
- Bausch + Lomb's Surgical Planning Software, Eyetelligence, Now Fully Commercially Available in UShttps://modernod.com/news/bausch-lombs-surgical-planning-software-eyetelligence-now-fully-commercially-available-in-us/2484204/Bausch + Lomb announced that its surgical planning software, Eyetelligence, is now available to all US ophthalmologists. Eyetelligence is designed to streamline a clinic’s operations and bring connectivity into the OR. According to B+L, the software helps surgeons make quick
- Contact Lens Institute Extends Partnership with Actress Kate Flannery for The EASY Way Campaignhttps://modernod.com/news/contact-lens-institute-extends-partnership-with-actress-kate-flannery-for-the-easy-way-campaign/2484132/The Contact Lens Institute (CLI) announced the continuation of its partnership with actress and comedian Kate Flannery to promote 'The EASY Way,' an initiative that aims to help eye care professionals encourage healthy contact lens wear-and-care b
- Bausch + Lomb Launches Blink Nourish and Blink Boost Lubricating Eye Drops in the UShttps://modernod.com/news/bausch-lomb-launches-blink-nourish-and-blink-boost-lubricating-eye-drops-in-the-us/2482834/Bausch + Lomb announced the US launch of Blink Nourish and Blink Boost lubricating eye drops. According to B+L, both products are preservative-free, contact-lens friendly and uniquely formulated to provide hydration and comfort for dry e
- Bausch + Lomb Receives CE Mark Approval for Preloaded LuxLife Full Range of Vision IOLshttps://modernod.com/news/bausch-lomb-receives-ce-mark-approval-for-preloaded-luxlife-full-range-of-vision-iols/2482789/Bausch + Lomb has received CE Mark approval for the LuxLife full range of vision IOLs. According to B+L, the preloaded IOL provides patients with natural, continuous vision, from distance to near. In a multicenter, comparative clinical study evaluating the LuxLife IOL versus t
- Nordic Pharma Launches Authorized Generic of Maxitrolhttps://modernod.com/news/nordic-pharma-launches-authorized-generic-of-maxitrol/2482759/Nordic Pharma announced a partnership with Harrow to launch an authorized generic of Maxitrol (Neomycin and Polymyxin B Sulfates and Dexamethasone ophthalmic suspension), for the treatment and relief of bacterial eye infections. Maxitrol and generic equivalents had a
- Bausch + Lomb Announces Voluntary Recall of enVista IOLshttps://modernod.com/news/bausch-lomb-announces-voluntary-recall-of-envista-iols/2482717/In response to an increased number of reports of toxic anterior segment syndrome (TASS), Bausch + Lomb announced a voluntary recall of IOLs on its enVista platform, including the enVista Aspire and enVista Envy IOLs, and certain enVista monofocal lenses in the US. B+
- Bausch + Lomb Makes Two Deals to Bolster Therapeutic Pipeline in GA and Glaucomahttps://modernod.com/news/bausch-lomb-makes-two-deals-to-bolster-therapeutic-pipeline-in-ga-and-glaucoma/2482612/Bausch + Lomb announced two separate deals to acquire early- and mid-stage therapeutic assets. First, B+L, through an affiliate, acquired Whitecap Biosciences LLC, which is developing two therapies for potential use in glaucoma and geographic atrophy (GA). Financial terms
- Bausch + Lomb Launches enVista Aspire Monofocal and Toric IOLs in the European Unionhttps://modernod.com/news/bausch-lomb-launches-envista-aspire-monofocal-and-toric-iols-in-the-european-union/2482610/Bausch + Lomb announced the commercial launch of the enVista Aspire monofocal and toric IOLs in the European Union after receiving a CE Mark late last year. According to B+L, enVista Aspire combines 'intermediate optimized' optics, which are designed for a broader dept
- Bausch + Lomb Acquires Elios Vision to Bolster Glaucoma Surgical Portfoliohttps://modernod.com/news/bausch-lomb-acquires-elios-vision-to-bolster-glaucoma-surgical-portfolio/2482575/Bausch + Lomb announced that an affiliate has acquired Elios Vision, developer of the ELIOS procedure, a minimally invasive glaucoma surgery (MIGS) procedure using an excimer laser. Financial terms of the deal were not disclosed. According to B+